Search Results
90 items found for "Rui-Hong Zhang"
- Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024
announced the winners of its Transforming Cancer Therapeutics grant, which focuses on developing life-changing
- Targeting Intracellular Allosteric Sites in GPCRs
and NAMs and thereby blocks the effects of positive and negative allosteric modulators (Rodriguez, Nong or more of the following pharmacological characteristics: 1) affinity modulation where the resulting change
- 📰 GPCR Weekly News, March 25 to March 31, 2024
Sosei Heptares Confirms Re-election of its Board and Executive Management Team and the Approval of Change
- Feeder or trigger – CCR2 as a scavenger and regulator of cell migration
2000), becoming incapable of promoting cell migration, a phenomenon which is likely to be mediated by changes
- Glyco-sulfo hotspots in the chemokine receptor system
extracellular loops and transmembrane domains of the receptor (CRS2), which will trigger conformational changes GSnP-6 displays nanomolar affinity and promising potential for blocking PSGL-1/P-selectin interaction (Wong
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
Artificial intelligence - Machine learning vs Deep Learning GPCRs have long been recognized as important predict subtype-selective ligands for dopamine receptors and adenosine receptors (He, Ben, Kuang, Wang & Kong , 2016; Kuang, Feng, Hu, Wang, He & Kong, 2016). 5. ability of a ligand to induce or inhibit a cellular response (pEC50 or pIC50, respectively), and how long , such as ligand binding sites (orthosteric, allosteric), activation mechanisms, and conformational changes